These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 25023698)
1. Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. De Mei C; Ercolani L; Parodi C; Veronesi M; Lo Vecchio C; Bottegoni G; Torrente E; Scarpelli R; Marotta R; Ruffili R; Mattioli M; Reggiani A; Wade M; Grimaldi B Oncogene; 2015 May; 34(20):2597-608. PubMed ID: 25023698 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in Vitro Anticancer Activity of the First Class of Dual Inhibitors of REV-ERBβ and Autophagy. Torrente E; Parodi C; Ercolani L; De Mei C; Ferrari A; Scarpelli R; Grimaldi B J Med Chem; 2015 Aug; 58(15):5900-15. PubMed ID: 26135471 [TBL] [Abstract][Full Text] [Related]
3. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy. Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508 [No Abstract] [Full Text] [Related]
4. Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle. Amador A; Campbell S; Kazantzis M; Lan G; Burris TP; Solt LA PLoS One; 2018; 13(5):e0196787. PubMed ID: 29723273 [TBL] [Abstract][Full Text] [Related]
5. REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output. Ikeda R; Tsuchiya Y; Koike N; Umemura Y; Inokawa H; Ono R; Inoue M; Sasawaki Y; Grieten T; Okubo N; Ikoma K; Fujiwara H; Kubo T; Yagita K Sci Rep; 2019 Jul; 9(1):10171. PubMed ID: 31308426 [TBL] [Abstract][Full Text] [Related]
6. Circadian clock: Time for novel anticancer strategies? Ercolani L; Ferrari A; De Mei C; Parodi C; Wade M; Grimaldi B Pharmacol Res; 2015 Oct; 100():288-95. PubMed ID: 26319800 [TBL] [Abstract][Full Text] [Related]
7. Role of Rev-erbα domains for transactivation of the connexin43 promoter with Sp1. Negoro H; Okinami T; Kanematsu A; Imamura M; Tabata Y; Ogawa O FEBS Lett; 2013 Jan; 587(1):98-103. PubMed ID: 23201262 [TBL] [Abstract][Full Text] [Related]
8. Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Bugge A; Feng D; Everett LJ; Briggs ER; Mullican SE; Wang F; Jager J; Lazar MA Genes Dev; 2012 Apr; 26(7):657-67. PubMed ID: 22474260 [TBL] [Abstract][Full Text] [Related]
9. Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist. Matta-Camacho E; Banerjee S; Hughes TS; Solt LA; Wang Y; Burris TP; Kojetin DJ J Biol Chem; 2014 Jul; 289(29):20054-66. PubMed ID: 24872411 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation and genetic deletion of REV-ERBα and REV-ERBβ regulates dendritic cell development. Amir M; Campbell S; Kamenecka TM; Solt LA Biochem Biophys Res Commun; 2020 Jul; 527(4):1000-1007. PubMed ID: 32439175 [TBL] [Abstract][Full Text] [Related]
11. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway. Kim K; Kim JH; Kim I; Seong S; Kim N Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression. Amador A; Wang Y; Banerjee S; Kameneka TM; Solt LA; Burris TP PLoS One; 2016; 11(3):e0151014. PubMed ID: 26963516 [TBL] [Abstract][Full Text] [Related]
13. A specific and unusual nuclear localization signal in the DNA binding domain of the Rev-erb orphan receptors. Chopin-Delannoy S; Thénot S; Delaunay F; Buisine E; Begue A; Duterque-Coquillaud M; Laudet V J Mol Endocrinol; 2003 Apr; 30(2):197-211. PubMed ID: 12683943 [TBL] [Abstract][Full Text] [Related]
14. A zinc finger HIT domain-containing protein, ZNHIT-1, interacts with orphan nuclear hormone receptor Rev-erbbeta and removes Rev-erbbeta-induced inhibition of apoCIII transcription. Wang J; Li Y; Zhang M; Liu Z; Wu C; Yuan H; Li YY; Zhao X; Lu H FEBS J; 2007 Oct; 274(20):5370-81. PubMed ID: 17892483 [TBL] [Abstract][Full Text] [Related]
15. REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009. Amador A; Kamenecka TM; Solt LA; Burris TP Biochem Pharmacol; 2018 Apr; 150():1-8. PubMed ID: 29355503 [TBL] [Abstract][Full Text] [Related]
16. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Raghuram S; Stayrook KR; Huang P; Rogers PM; Nosie AK; McClure DB; Burris LL; Khorasanizadeh S; Burris TP; Rastinejad F Nat Struct Mol Biol; 2007 Dec; 14(12):1207-13. PubMed ID: 18037887 [TBL] [Abstract][Full Text] [Related]
17. High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor. Carter EL; Gupta N; Ragsdale SW J Biol Chem; 2016 Jan; 291(5):2196-222. PubMed ID: 26670607 [TBL] [Abstract][Full Text] [Related]
18. Molecular Dynamics of Cobalt Protoporphyrin Antagonism of the Cancer Suppressor REV-ERBβ. Fakih TM; Kurniawan F; Yusuf M; Mudasir M; Tjahjono DH Molecules; 2021 May; 26(11):. PubMed ID: 34071361 [TBL] [Abstract][Full Text] [Related]
19. Domain-Specific Monoclonal Antibodies Against Human Rev-erbβ. Chen F; Li Y; Zhao J; Mao Q; Xia H Appl Biochem Biotechnol; 2017 Jul; 182(3):978-989. PubMed ID: 27987190 [TBL] [Abstract][Full Text] [Related]
20. The REV-ERB Nuclear Receptors: Timekeepers for the Core Clock Period and Metabolism. Adlanmerini M; Lazar MA Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37149727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]